Search

everythinglearnresearchcommunity

for

Search:↓

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Young women with PCOS without additional risk factors may have normal heart function.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

No effective treatment for hair loss after childbirth was found, but it usually gets better on its own and some cosmetic methods might help.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Azelaic Acid is effective and safe for treating adult female acne, with few side effects.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Menopause can cause skin issues, and seeing a dermatologist helps.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Polycystic ovary syndrome (PCOS) is a major health issue for women in Egypt, affecting 14% of fertile women and 37.5% of infertile women.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Young women with PCOS and no other heart risk factors have normal heart function.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.